Global Chagas Disease Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Chagas Disease Drug will have significant change from previous year. According to our (LP Information) latest study, the global Chagas Disease Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Chagas Disease Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Chagas Disease Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Chagas Disease Drug market, reaching US$ million by the year 2028. As for the Europe Chagas Disease Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Chagas Disease Drug players cover AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd, and Eisai Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chagas Disease Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Chagas Disease Drug will have significant change from previous year. According to our (LP Information) latest study, the global Chagas Disease Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Chagas Disease Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Chagas Disease Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Chagas Disease Drug market, reaching US$ million by the year 2028. As for the Europe Chagas Disease Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Chagas Disease Drug players cover AstraZeneca Plc, Bayer AG, Daiichi Sankyo Co Ltd, and Eisai Co Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Chagas Disease Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Cz-007
- Cz-008
- D-121
- DNDI-0690
- EPLBS-1246
- EPLBS-967
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca Plc
- Bayer AG
- Daiichi Sankyo Co Ltd
- Eisai Co Ltd
- GlaxoSmithKline Plc
- Grupo Praxis Pharmaceutical SA
- Humanigen Inc
- Kancera AB
- Merck & Co Inc
- Novartis AG
- Oblita Therapeutics BVBA
- Sanofi
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chagas Disease Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chagas Disease Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chagas Disease Drug by Country/Region, 2017, 2022 & 2028
2.2 Chagas Disease Drug Segment by Type
2.2.1 Cz-007
2.2.2 Cz-008
2.2.3 D-121
2.2.4 DNDI-0690
2.2.5 EPLBS-1246
2.2.6 EPLBS-967
2.2.7 Others
2.3 Chagas Disease Drug Sales by Type
2.3.1 Global Chagas Disease Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Chagas Disease Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Chagas Disease Drug Sale Price by Type (2017-2022)
2.4 Chagas Disease Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Chagas Disease Drug Sales by Application
2.5.1 Global Chagas Disease Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Chagas Disease Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chagas Disease Drug Sale Price by Application (2017-2022)
3 GLOBAL CHAGAS DISEASE DRUG BY COMPANY
3.1 Global Chagas Disease Drug Breakdown Data by Company
3.1.1 Global Chagas Disease Drug Annual Sales by Company (2020-2022)
3.1.2 Global Chagas Disease Drug Sales Market Share by Company (2020-2022)
3.2 Global Chagas Disease Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Chagas Disease Drug Revenue by Company (2020-2022)
3.2.2 Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)
3.3 Global Chagas Disease Drug Sale Price by Company
3.4 Key Manufacturers Chagas Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chagas Disease Drug Product Location Distribution
3.4.2 Players Chagas Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHAGAS DISEASE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Chagas Disease Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Chagas Disease Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chagas Disease Drug Annual Revenue by Geographic Region
4.2 World Historic Chagas Disease Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Chagas Disease Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chagas Disease Drug Annual Revenue by Country/Region
4.3 Americas Chagas Disease Drug Sales Growth
4.4 APAC Chagas Disease Drug Sales Growth
4.5 Europe Chagas Disease Drug Sales Growth
4.6 Middle East & Africa Chagas Disease Drug Sales Growth
5 AMERICAS
5.1 Americas Chagas Disease Drug Sales by Country
5.1.1 Americas Chagas Disease Drug Sales by Country (2017-2022)
5.1.2 Americas Chagas Disease Drug Revenue by Country (2017-2022)
5.2 Americas Chagas Disease Drug Sales by Type
5.3 Americas Chagas Disease Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chagas Disease Drug Sales by Region
6.1.1 APAC Chagas Disease Drug Sales by Region (2017-2022)
6.1.2 APAC Chagas Disease Drug Revenue by Region (2017-2022)
6.2 APAC Chagas Disease Drug Sales by Type
6.3 APAC Chagas Disease Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chagas Disease Drug by Country
7.1.1 Europe Chagas Disease Drug Sales by Country (2017-2022)
7.1.2 Europe Chagas Disease Drug Revenue by Country (2017-2022)
7.2 Europe Chagas Disease Drug Sales by Type
7.3 Europe Chagas Disease Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chagas Disease Drug by Country
8.1.1 Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Chagas Disease Drug Sales by Type
8.3 Middle East & Africa Chagas Disease Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
10.3 Manufacturing Process Analysis of Chagas Disease Drug
10.4 Industry Chain Structure of Chagas Disease Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chagas Disease Drug Distributors
11.3 Chagas Disease Drug Customer
12 WORLD FORECAST REVIEW FOR CHAGAS DISEASE DRUG BY GEOGRAPHIC REGION
12.1 Global Chagas Disease Drug Market Size Forecast by Region
12.1.1 Global Chagas Disease Drug Forecast by Region (2023-2028)
12.1.2 Global Chagas Disease Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chagas Disease Drug Forecast by Type
12.7 Global Chagas Disease Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca Plc
13.1.1 AstraZeneca Plc Company Information
13.1.2 AstraZeneca Plc Chagas Disease Drug Product Offered
13.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Plc Main Business Overview
13.1.5 AstraZeneca Plc Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Chagas Disease Drug Product Offered
13.2.3 Bayer AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Daiichi Sankyo Co Ltd
13.3.1 Daiichi Sankyo Co Ltd Company Information
13.3.2 Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered
13.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Daiichi Sankyo Co Ltd Main Business Overview
13.3.5 Daiichi Sankyo Co Ltd Latest Developments
13.4 Eisai Co Ltd
13.4.1 Eisai Co Ltd Company Information
13.4.2 Eisai Co Ltd Chagas Disease Drug Product Offered
13.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eisai Co Ltd Main Business Overview
13.4.5 Eisai Co Ltd Latest Developments
13.5 GlaxoSmithKline Plc
13.5.1 GlaxoSmithKline Plc Company Information
13.5.2 GlaxoSmithKline Plc Chagas Disease Drug Product Offered
13.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Plc Main Business Overview
13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 Grupo Praxis Pharmaceutical SA
13.6.1 Grupo Praxis Pharmaceutical SA Company Information
13.6.2 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered
13.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Grupo Praxis Pharmaceutical SA Main Business Overview
13.6.5 Grupo Praxis Pharmaceutical SA Latest Developments
13.7 Humanigen Inc
13.7.1 Humanigen Inc Company Information
13.7.2 Humanigen Inc Chagas Disease Drug Product Offered
13.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Humanigen Inc Main Business Overview
13.7.5 Humanigen Inc Latest Developments
13.8 Kancera AB
13.8.1 Kancera AB Company Information
13.8.2 Kancera AB Chagas Disease Drug Product Offered
13.8.3 Kancera AB Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kancera AB Main Business Overview
13.8.5 Kancera AB Latest Developments
13.9 Merck & Co Inc
13.9.1 Merck & Co Inc Company Information
13.9.2 Merck & Co Inc Chagas Disease Drug Product Offered
13.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck & Co Inc Main Business Overview
13.9.5 Merck & Co Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Chagas Disease Drug Product Offered
13.10.3 Novartis AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Oblita Therapeutics BVBA
13.11.1 Oblita Therapeutics BVBA Company Information
13.11.2 Oblita Therapeutics BVBA Chagas Disease Drug Product Offered
13.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Oblita Therapeutics BVBA Main Business Overview
13.11.5 Oblita Therapeutics BVBA Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Chagas Disease Drug Product Offered
13.12.3 Sanofi Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chagas Disease Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Chagas Disease Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Chagas Disease Drug by Country/Region, 2017, 2022 & 2028
2.2 Chagas Disease Drug Segment by Type
2.2.1 Cz-007
2.2.2 Cz-008
2.2.3 D-121
2.2.4 DNDI-0690
2.2.5 EPLBS-1246
2.2.6 EPLBS-967
2.2.7 Others
2.3 Chagas Disease Drug Sales by Type
2.3.1 Global Chagas Disease Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Chagas Disease Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Chagas Disease Drug Sale Price by Type (2017-2022)
2.4 Chagas Disease Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Chagas Disease Drug Sales by Application
2.5.1 Global Chagas Disease Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Chagas Disease Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Chagas Disease Drug Sale Price by Application (2017-2022)
3 GLOBAL CHAGAS DISEASE DRUG BY COMPANY
3.1 Global Chagas Disease Drug Breakdown Data by Company
3.1.1 Global Chagas Disease Drug Annual Sales by Company (2020-2022)
3.1.2 Global Chagas Disease Drug Sales Market Share by Company (2020-2022)
3.2 Global Chagas Disease Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Chagas Disease Drug Revenue by Company (2020-2022)
3.2.2 Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)
3.3 Global Chagas Disease Drug Sale Price by Company
3.4 Key Manufacturers Chagas Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chagas Disease Drug Product Location Distribution
3.4.2 Players Chagas Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHAGAS DISEASE DRUG BY GEOGRAPHIC REGION
4.1 World Historic Chagas Disease Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Chagas Disease Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Chagas Disease Drug Annual Revenue by Geographic Region
4.2 World Historic Chagas Disease Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Chagas Disease Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Chagas Disease Drug Annual Revenue by Country/Region
4.3 Americas Chagas Disease Drug Sales Growth
4.4 APAC Chagas Disease Drug Sales Growth
4.5 Europe Chagas Disease Drug Sales Growth
4.6 Middle East & Africa Chagas Disease Drug Sales Growth
5 AMERICAS
5.1 Americas Chagas Disease Drug Sales by Country
5.1.1 Americas Chagas Disease Drug Sales by Country (2017-2022)
5.1.2 Americas Chagas Disease Drug Revenue by Country (2017-2022)
5.2 Americas Chagas Disease Drug Sales by Type
5.3 Americas Chagas Disease Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chagas Disease Drug Sales by Region
6.1.1 APAC Chagas Disease Drug Sales by Region (2017-2022)
6.1.2 APAC Chagas Disease Drug Revenue by Region (2017-2022)
6.2 APAC Chagas Disease Drug Sales by Type
6.3 APAC Chagas Disease Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chagas Disease Drug by Country
7.1.1 Europe Chagas Disease Drug Sales by Country (2017-2022)
7.1.2 Europe Chagas Disease Drug Revenue by Country (2017-2022)
7.2 Europe Chagas Disease Drug Sales by Type
7.3 Europe Chagas Disease Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chagas Disease Drug by Country
8.1.1 Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Chagas Disease Drug Sales by Type
8.3 Middle East & Africa Chagas Disease Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
10.3 Manufacturing Process Analysis of Chagas Disease Drug
10.4 Industry Chain Structure of Chagas Disease Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chagas Disease Drug Distributors
11.3 Chagas Disease Drug Customer
12 WORLD FORECAST REVIEW FOR CHAGAS DISEASE DRUG BY GEOGRAPHIC REGION
12.1 Global Chagas Disease Drug Market Size Forecast by Region
12.1.1 Global Chagas Disease Drug Forecast by Region (2023-2028)
12.1.2 Global Chagas Disease Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chagas Disease Drug Forecast by Type
12.7 Global Chagas Disease Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca Plc
13.1.1 AstraZeneca Plc Company Information
13.1.2 AstraZeneca Plc Chagas Disease Drug Product Offered
13.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Plc Main Business Overview
13.1.5 AstraZeneca Plc Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Chagas Disease Drug Product Offered
13.2.3 Bayer AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 Daiichi Sankyo Co Ltd
13.3.1 Daiichi Sankyo Co Ltd Company Information
13.3.2 Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered
13.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Daiichi Sankyo Co Ltd Main Business Overview
13.3.5 Daiichi Sankyo Co Ltd Latest Developments
13.4 Eisai Co Ltd
13.4.1 Eisai Co Ltd Company Information
13.4.2 Eisai Co Ltd Chagas Disease Drug Product Offered
13.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eisai Co Ltd Main Business Overview
13.4.5 Eisai Co Ltd Latest Developments
13.5 GlaxoSmithKline Plc
13.5.1 GlaxoSmithKline Plc Company Information
13.5.2 GlaxoSmithKline Plc Chagas Disease Drug Product Offered
13.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GlaxoSmithKline Plc Main Business Overview
13.5.5 GlaxoSmithKline Plc Latest Developments
13.6 Grupo Praxis Pharmaceutical SA
13.6.1 Grupo Praxis Pharmaceutical SA Company Information
13.6.2 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered
13.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Grupo Praxis Pharmaceutical SA Main Business Overview
13.6.5 Grupo Praxis Pharmaceutical SA Latest Developments
13.7 Humanigen Inc
13.7.1 Humanigen Inc Company Information
13.7.2 Humanigen Inc Chagas Disease Drug Product Offered
13.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Humanigen Inc Main Business Overview
13.7.5 Humanigen Inc Latest Developments
13.8 Kancera AB
13.8.1 Kancera AB Company Information
13.8.2 Kancera AB Chagas Disease Drug Product Offered
13.8.3 Kancera AB Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kancera AB Main Business Overview
13.8.5 Kancera AB Latest Developments
13.9 Merck & Co Inc
13.9.1 Merck & Co Inc Company Information
13.9.2 Merck & Co Inc Chagas Disease Drug Product Offered
13.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Merck & Co Inc Main Business Overview
13.9.5 Merck & Co Inc Latest Developments
13.10 Novartis AG
13.10.1 Novartis AG Company Information
13.10.2 Novartis AG Chagas Disease Drug Product Offered
13.10.3 Novartis AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis AG Main Business Overview
13.10.5 Novartis AG Latest Developments
13.11 Oblita Therapeutics BVBA
13.11.1 Oblita Therapeutics BVBA Company Information
13.11.2 Oblita Therapeutics BVBA Chagas Disease Drug Product Offered
13.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Oblita Therapeutics BVBA Main Business Overview
13.11.5 Oblita Therapeutics BVBA Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Chagas Disease Drug Product Offered
13.12.3 Sanofi Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chagas Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chagas Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Cz-007
Table 4. Major Players of Cz-008
Table 5. Major Players of D-121
Table 6. Major Players of DNDI-0690
Table 7. Major Players of EPLBS-1246
Table 8. Major Players of EPLBS-967
Table 9. Major Players of Others
Table 10. Global Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 12. Global Chagas Disease Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Chagas Disease Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 17. Global Chagas Disease Drug Revenue by Application (2017-2022)
Table 18. Global Chagas Disease Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Chagas Disease Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Chagas Disease Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Chagas Disease Drug Sales Market Share by Company (2020-2022)
Table 22. Global Chagas Disease Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Chagas Disease Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Chagas Disease Drug Producing Area Distribution and Sales Area
Table 26. Players Chagas Disease Drug Products Offered
Table 27. Chagas Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Chagas Disease Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Chagas Disease Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Chagas Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Chagas Disease Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Chagas Disease Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Chagas Disease Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Chagas Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Chagas Disease Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Chagas Disease Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Chagas Disease Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Chagas Disease Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Chagas Disease Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Chagas Disease Drug
Table 71. Key Market Challenges & Risks of Chagas Disease Drug
Table 72. Key Industry Trends of Chagas Disease Drug
Table 73. Chagas Disease Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Chagas Disease Drug Distributors List
Table 76. Chagas Disease Drug Customer List
Table 77. Global Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Chagas Disease Drug Sales Market Forecast by Region
Table 79. Global Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Chagas Disease Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Chagas Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Chagas Disease Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Chagas Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Chagas Disease Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Chagas Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Chagas Disease Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Chagas Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Chagas Disease Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. AstraZeneca Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Plc Chagas Disease Drug Product Offered
Table 99. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. AstraZeneca Plc Main Business
Table 101. AstraZeneca Plc Latest Developments
Table 102. Bayer AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Chagas Disease Drug Product Offered
Table 104. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Daiichi Sankyo Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered
Table 109. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Daiichi Sankyo Co Ltd Main Business
Table 111. Daiichi Sankyo Co Ltd Latest Developments
Table 112. Eisai Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Eisai Co Ltd Chagas Disease Drug Product Offered
Table 114. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Eisai Co Ltd Main Business
Table 116. Eisai Co Ltd Latest Developments
Table 117. GlaxoSmithKline Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. GlaxoSmithKline Plc Chagas Disease Drug Product Offered
Table 119. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. GlaxoSmithKline Plc Main Business
Table 121. GlaxoSmithKline Plc Latest Developments
Table 122. Grupo Praxis Pharmaceutical SA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered
Table 124. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Grupo Praxis Pharmaceutical SA Main Business
Table 126. Grupo Praxis Pharmaceutical SA Latest Developments
Table 127. Humanigen Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Humanigen Inc Chagas Disease Drug Product Offered
Table 129. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Humanigen Inc Main Business
Table 131. Humanigen Inc Latest Developments
Table 132. Kancera AB Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Kancera AB Chagas Disease Drug Product Offered
Table 134. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Kancera AB Main Business
Table 136. Kancera AB Latest Developments
Table 137. Merck & Co Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Merck & Co Inc Chagas Disease Drug Product Offered
Table 139. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Merck & Co Inc Main Business
Table 141. Merck & Co Inc Latest Developments
Table 142. Novartis AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Novartis AG Chagas Disease Drug Product Offered
Table 144. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Novartis AG Main Business
Table 146. Novartis AG Latest Developments
Table 147. Oblita Therapeutics BVBA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Oblita Therapeutics BVBA Chagas Disease Drug Product Offered
Table 149. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Oblita Therapeutics BVBA Main Business
Table 151. Oblita Therapeutics BVBA Latest Developments
Table 152. Sanofi Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Sanofi Chagas Disease Drug Product Offered
Table 154. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Sanofi Main Business
Table 156. Sanofi Latest Developments
Table 1. Chagas Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Chagas Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Cz-007
Table 4. Major Players of Cz-008
Table 5. Major Players of D-121
Table 6. Major Players of DNDI-0690
Table 7. Major Players of EPLBS-1246
Table 8. Major Players of EPLBS-967
Table 9. Major Players of Others
Table 10. Global Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 11. Global Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 12. Global Chagas Disease Drug Revenue by Type (2017-2022) & ($ million)
Table 13. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)
Table 14. Global Chagas Disease Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 15. Global Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 16. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 17. Global Chagas Disease Drug Revenue by Application (2017-2022)
Table 18. Global Chagas Disease Drug Revenue Market Share by Application (2017-2022)
Table 19. Global Chagas Disease Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 20. Global Chagas Disease Drug Sales by Company (2020-2022) & (K Pcs)
Table 21. Global Chagas Disease Drug Sales Market Share by Company (2020-2022)
Table 22. Global Chagas Disease Drug Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Chagas Disease Drug Revenue Market Share by Company (2020-2022)
Table 24. Global Chagas Disease Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 25. Key Manufacturers Chagas Disease Drug Producing Area Distribution and Sales Area
Table 26. Players Chagas Disease Drug Products Offered
Table 27. Chagas Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Chagas Disease Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 31. Global Chagas Disease Drug Sales Market Share Geographic Region (2017-2022)
Table 32. Global Chagas Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Chagas Disease Drug Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Chagas Disease Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 35. Global Chagas Disease Drug Sales Market Share by Country/Region (2017-2022)
Table 36. Global Chagas Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Chagas Disease Drug Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 39. Americas Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 40. Americas Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 42. Americas Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 43. Americas Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 44. Americas Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 45. Americas Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 46. APAC Chagas Disease Drug Sales by Region (2017-2022) & (K Pcs)
Table 47. APAC Chagas Disease Drug Sales Market Share by Region (2017-2022)
Table 48. APAC Chagas Disease Drug Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Chagas Disease Drug Revenue Market Share by Region (2017-2022)
Table 50. APAC Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. APAC Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 52. APAC Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 53. APAC Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 54. Europe Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 56. Europe Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 58. Europe Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 60. Europe Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Chagas Disease Drug Sales by Country (2017-2022) & (K Pcs)
Table 63. Middle East & Africa Chagas Disease Drug Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Chagas Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Chagas Disease Drug Sales by Type (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Chagas Disease Drug Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Chagas Disease Drug Sales by Application (2017-2022) & (K Pcs)
Table 69. Middle East & Africa Chagas Disease Drug Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Chagas Disease Drug
Table 71. Key Market Challenges & Risks of Chagas Disease Drug
Table 72. Key Industry Trends of Chagas Disease Drug
Table 73. Chagas Disease Drug Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Chagas Disease Drug Distributors List
Table 76. Chagas Disease Drug Customer List
Table 77. Global Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 78. Global Chagas Disease Drug Sales Market Forecast by Region
Table 79. Global Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Chagas Disease Drug Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 82. Americas Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Chagas Disease Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 84. APAC Chagas Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Europe Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Chagas Disease Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 88. Middle East & Africa Chagas Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Chagas Disease Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 90. Global Chagas Disease Drug Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Chagas Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Chagas Disease Drug Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Chagas Disease Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 94. Global Chagas Disease Drug Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Chagas Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Chagas Disease Drug Revenue Market Share Forecast by Application (2023-2028)
Table 97. AstraZeneca Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Plc Chagas Disease Drug Product Offered
Table 99. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. AstraZeneca Plc Main Business
Table 101. AstraZeneca Plc Latest Developments
Table 102. Bayer AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Chagas Disease Drug Product Offered
Table 104. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Daiichi Sankyo Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Daiichi Sankyo Co Ltd Chagas Disease Drug Product Offered
Table 109. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Daiichi Sankyo Co Ltd Main Business
Table 111. Daiichi Sankyo Co Ltd Latest Developments
Table 112. Eisai Co Ltd Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Eisai Co Ltd Chagas Disease Drug Product Offered
Table 114. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Eisai Co Ltd Main Business
Table 116. Eisai Co Ltd Latest Developments
Table 117. GlaxoSmithKline Plc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. GlaxoSmithKline Plc Chagas Disease Drug Product Offered
Table 119. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. GlaxoSmithKline Plc Main Business
Table 121. GlaxoSmithKline Plc Latest Developments
Table 122. Grupo Praxis Pharmaceutical SA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Offered
Table 124. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Grupo Praxis Pharmaceutical SA Main Business
Table 126. Grupo Praxis Pharmaceutical SA Latest Developments
Table 127. Humanigen Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Humanigen Inc Chagas Disease Drug Product Offered
Table 129. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Humanigen Inc Main Business
Table 131. Humanigen Inc Latest Developments
Table 132. Kancera AB Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Kancera AB Chagas Disease Drug Product Offered
Table 134. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Kancera AB Main Business
Table 136. Kancera AB Latest Developments
Table 137. Merck & Co Inc Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Merck & Co Inc Chagas Disease Drug Product Offered
Table 139. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Merck & Co Inc Main Business
Table 141. Merck & Co Inc Latest Developments
Table 142. Novartis AG Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Novartis AG Chagas Disease Drug Product Offered
Table 144. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Novartis AG Main Business
Table 146. Novartis AG Latest Developments
Table 147. Oblita Therapeutics BVBA Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Oblita Therapeutics BVBA Chagas Disease Drug Product Offered
Table 149. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Oblita Therapeutics BVBA Main Business
Table 151. Oblita Therapeutics BVBA Latest Developments
Table 152. Sanofi Basic Information, Chagas Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Sanofi Chagas Disease Drug Product Offered
Table 154. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Sanofi Main Business
Table 156. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chagas Disease Drug
Figure 2. Chagas Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chagas Disease Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Chagas Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chagas Disease Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Cz-007
Figure 10. Product Picture of Cz-008
Figure 11. Product Picture of D-121
Figure 12. Product Picture of DNDI-0690
Figure 13. Product Picture of EPLBS-1246
Figure 14. Product Picture of EPLBS-967
Figure 15. Product Picture of Others
Figure 16. Global Chagas Disease Drug Sales Market Share by Type in 2021
Figure 17. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)
Figure 18. Chagas Disease Drug Consumed in Hospital
Figure 19. Global Chagas Disease Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Chagas Disease Drug Consumed in Clinic
Figure 21. Global Chagas Disease Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Chagas Disease Drug Consumed in Others
Figure 23. Global Chagas Disease Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Chagas Disease Drug Revenue Market Share by Application in 2021
Figure 26. Chagas Disease Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Chagas Disease Drug Revenue Market Share by Company in 2021
Figure 28. Global Chagas Disease Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Chagas Disease Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Chagas Disease Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Chagas Disease Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Chagas Disease Drug Sales Market Share by Country in 2021
Figure 41. Americas Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 42. United States Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Chagas Disease Drug Sales Market Share by Region in 2021
Figure 47. APAC Chagas Disease Drug Revenue Market Share by Regions in 2021
Figure 48. China Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Chagas Disease Drug Sales Market Share by Country in 2021
Figure 55. Europe Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 56. Germany Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Chagas Disease Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2021
Figure 69. Manufacturing Process Analysis of Chagas Disease Drug
Figure 70. Industry Chain Structure of Chagas Disease Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Chagas Disease Drug
Figure 2. Chagas Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chagas Disease Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Chagas Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Chagas Disease Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Cz-007
Figure 10. Product Picture of Cz-008
Figure 11. Product Picture of D-121
Figure 12. Product Picture of DNDI-0690
Figure 13. Product Picture of EPLBS-1246
Figure 14. Product Picture of EPLBS-967
Figure 15. Product Picture of Others
Figure 16. Global Chagas Disease Drug Sales Market Share by Type in 2021
Figure 17. Global Chagas Disease Drug Revenue Market Share by Type (2017-2022)
Figure 18. Chagas Disease Drug Consumed in Hospital
Figure 19. Global Chagas Disease Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Chagas Disease Drug Consumed in Clinic
Figure 21. Global Chagas Disease Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 22. Chagas Disease Drug Consumed in Others
Figure 23. Global Chagas Disease Drug Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Chagas Disease Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Chagas Disease Drug Revenue Market Share by Application in 2021
Figure 26. Chagas Disease Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Chagas Disease Drug Revenue Market Share by Company in 2021
Figure 28. Global Chagas Disease Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Chagas Disease Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Chagas Disease Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Chagas Disease Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 33. Americas Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 35. APAC Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 37. Europe Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Chagas Disease Drug Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Chagas Disease Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Chagas Disease Drug Sales Market Share by Country in 2021
Figure 41. Americas Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 42. United States Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Chagas Disease Drug Sales Market Share by Region in 2021
Figure 47. APAC Chagas Disease Drug Revenue Market Share by Regions in 2021
Figure 48. China Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Chagas Disease Drug Sales Market Share by Country in 2021
Figure 55. Europe Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 56. Germany Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Chagas Disease Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Chagas Disease Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Chagas Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2021
Figure 69. Manufacturing Process Analysis of Chagas Disease Drug
Figure 70. Industry Chain Structure of Chagas Disease Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
